Pectin-based double network hydrogels as local depots of celastrol for enhanced antitumor therapy

Int J Biol Macromol. 2024 Jan;256(Pt 2):128442. doi: 10.1016/j.ijbiomac.2023.128442. Epub 2023 Nov 28.

Abstract

In this study, A double-network (DN) hydrogel composed of a physical glycyrrhizic acid (GA) network and a chemically crosslinked pectin-based network was fabricated as a local depot of celastrol (CEL) for cancer treatment. The obtained DN hydrogel possessed excellent mechanical performance, flexibility, biocompatibility, biodegradability and self-healing property. Furthermore, the release profile of CEL loaded DN hydrogel maintained a controlled and sustained release of CEL for a prolonged period. Finally, in vivo animal experiments demonstrated that the DN hydrogel could significantly enhance the therapeutic efficiency of CEL in CT-26 tumor-bearing mice upon intratumoral injection while effectively alleviate the toxicity of the CEL. In summary, this injectable pectin-based double network hydrogels are ideal delivery vehicle for tumor therapy.

Keywords: Antitumor therapy; Celastrol; Double network hydrogel; Pectin; Self-healing.

MeSH terms

  • Animals
  • Hydrogels* / chemistry
  • Mice
  • Neoplasms* / drug therapy
  • Pectins / chemistry
  • Pentacyclic Triterpenes

Substances

  • Hydrogels
  • celastrol
  • Pectins
  • Pentacyclic Triterpenes